239 related articles for article (PubMed ID: 10601010)
1. Crystal structure of calpain reveals the structural basis for Ca(2+)-dependent protease activity and a novel mode of enzyme activation.
Hosfield CM; Elce JS; Davies PL; Jia Z
EMBO J; 1999 Dec; 18(24):6880-9. PubMed ID: 10601010
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of human grancalcin, a member of the penta-EF-hand protein family.
Jia J; Han Q; Borregaard N; Lollike K; Cygler M
J Mol Biol; 2000 Jul; 300(5):1271-81. PubMed ID: 10903868
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for possible calcium-induced activation mechanisms of calpains.
Reverter D; Strobl S; Fernandez-Catalan C; Sorimachi H; Suzuki K; Bode W
Biol Chem; 2001 May; 382(5):753-66. PubMed ID: 11517928
[TBL] [Abstract][Full Text] [Related]
4. Roles of individual EF-hands in the activation of m-calpain by calcium.
Dutt P; Arthur JS; Grochulski P; Cygler M; Elce JS
Biochem J; 2000 May; 348 Pt 1(Pt 1):37-43. PubMed ID: 10794711
[TBL] [Abstract][Full Text] [Related]
5. Calpain silencing by a reversible intrinsic mechanism.
Moldoveanu T; Hosfield CM; Lim D; Jia Z; Davies PL
Nat Struct Biol; 2003 May; 10(5):371-8. PubMed ID: 12665854
[TBL] [Abstract][Full Text] [Related]
6. Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin.
Hanna RA; Campbell RL; Davies PL
Nature; 2008 Nov; 456(7220):409-12. PubMed ID: 19020623
[TBL] [Abstract][Full Text] [Related]
7. Crystallization and structural details of Ca(2+)-induced conformational changes in the EF-hand domain VI of calpain.
Cygler M; Grochulski P; Blanchard H
Methods Mol Biol; 2002; 172():243-60. PubMed ID: 11833352
[No Abstract] [Full Text] [Related]
8. Mu-calpain binds to lipid bilayers via the exposed hydrophobic surface of its Ca2+-activated conformation.
Fernández-Montalván A; Assfalg-Machleidt I; Pfeiler D; Fritz H; Jochum M; Machleidt W
Biol Chem; 2006 May; 387(5):617-27. PubMed ID: 16740134
[TBL] [Abstract][Full Text] [Related]
9. Distinguishing between calpain heterodimerization and homodimerization.
Ravulapalli R; Campbell RL; Gauthier SY; Dhe-Paganon S; Davies PL
FEBS J; 2009 Feb; 276(4):973-82. PubMed ID: 19215300
[TBL] [Abstract][Full Text] [Related]
10. Flexibility analysis and structure comparison of two crystal forms of calcium-free human m-calpain.
Reverter D; Braun M; Fernandez-Catalan C; Strobl S; Sorimachi H; Bode W
Biol Chem; 2002 Sep; 383(9):1415-22. PubMed ID: 12437134
[TBL] [Abstract][Full Text] [Related]
11. Calpain inhibition by alpha-ketoamide and cyclic hemiacetal inhibitors revealed by X-ray crystallography.
Cuerrier D; Moldoveanu T; Inoue J; Davies PL; Campbell RL
Biochemistry; 2006 Jun; 45(24):7446-52. PubMed ID: 16768440
[TBL] [Abstract][Full Text] [Related]
12. A second binding site revealed by C-terminal truncation of calpain small subunit, a penta-EF-hand protein.
Leinala EK; Arthur JS; Grochulski P; Davies PL; Elce JS; Jia Z
Proteins; 2003 Nov; 53(3):649-55. PubMed ID: 14579356
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of calpain-3 penta-EF-hand (PEF) domain - a homodimerized PEF family member with calcium bound at the fifth EF-hand.
Partha SK; Ravulapalli R; Allingham JS; Campbell RL; Davies PL
FEBS J; 2014 Jul; 281(14):3138-49. PubMed ID: 24846670
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for Ca(2+)-induced activation of human PAD4.
Arita K; Hashimoto H; Shimizu T; Nakashima K; Yamada M; Sato M
Nat Struct Mol Biol; 2004 Aug; 11(8):777-83. PubMed ID: 15247907
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of an activation intermediate of cathepsin E.
Ostermann N; Gerhartz B; Worpenberg S; Trappe J; Eder J
J Mol Biol; 2004 Sep; 342(3):889-99. PubMed ID: 15342244
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of calpain and insights into Ca(2+)-dependent activation.
Jia Z; Hosfield CM; Davies PL; Elce JS
Methods Mol Biol; 2002; 172():51-67. PubMed ID: 11833359
[No Abstract] [Full Text] [Related]
17. Structures of dimeric nonstandard nucleotide triphosphate pyrophosphatase from Pyrococcus horikoshii OT3: functional significance of interprotomer conformational changes.
Lokanath NK; Pampa KJ; Takio K; Kunishima N
J Mol Biol; 2008 Jan; 375(4):1013-25. PubMed ID: 18062990
[TBL] [Abstract][Full Text] [Related]
18. Vmax regulation through domain and subunit changes. The active form of phosphoglycerate dehydrogenase.
Thompson JR; Bell JK; Bratt J; Grant GA; Banaszak LJ
Biochemistry; 2005 Apr; 44(15):5763-73. PubMed ID: 15823035
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of HslUV complexed with a vinyl sulfone inhibitor: corroboration of a proposed mechanism of allosteric activation of HslV by HslU.
Sousa MC; Kessler BM; Overkleeft HS; McKay DB
J Mol Biol; 2002 May; 318(3):779-85. PubMed ID: 12054822
[TBL] [Abstract][Full Text] [Related]
20. Origins of the difference in Ca2+ requirement for activation of mu- and m-calpain.
Dutt P; Spriggs CN; Davies PL; Jia Z; Elce JS
Biochem J; 2002 Oct; 367(Pt 1):263-9. PubMed ID: 12014988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
